PlainRecalls
FDA Drug Moderate Class II Terminated

Sermorelin Acetate/GHRP (2) 9 mg/3 mg Injectable Kit, Compounded by Wells Pharmacy, Ocala FL

Reported: January 11, 2017 Initiated: September 21, 2016 #D-0395-2017

Product Description

Sermorelin Acetate/GHRP (2) 9 mg/3 mg Injectable Kit, Compounded by Wells Pharmacy, Ocala FL

Reason for Recall

Lack of Assurance of Sterility

Details

Units Affected
2,264 kits (number of vials per kit vary by prescription)
Distribution
Nationwide
Location
Ocala, FL

Frequently Asked Questions

What product was recalled?
Sermorelin Acetate/GHRP (2) 9 mg/3 mg Injectable Kit, Compounded by Wells Pharmacy, Ocala FL. Recalled by Wells Pharmacy Network LLC. Units affected: 2,264 kits (number of vials per kit vary by prescription).
Why was this product recalled?
Lack of Assurance of Sterility
Which agency issued this recall?
This recall was issued by the FDA Drug on January 11, 2017. Severity: Moderate. Recall number: D-0395-2017.